Controversies in neonatology: The efficacy of inhaled nitric oxide in preterm infants with persistent pulmonary hypertension-Reference-Cited by-同舟云学术

Controversies in neonatology: The efficacy of inhaled nitric oxide in preterm infants with persistent pulmonary hypertension

Published:2022-09-25 Issue:5 Volume:5 Page:1303-1311
ISSN:2636-8579
Container-title:Journal of Health Sciences and Medicine
language:en
Short-container-title:J Health Sci Med / JHSM

Author:

VARDAR Gonca¹,AKSOY OKAN Meliha¹,TOPÇUOĞLU Sevilay¹,KARADAĞ Nilgün¹,ÖZALKAYA Elif¹,OZGUN KARATEPE Hande¹,KARATEKİN Güner¹

Affiliation:

1. UNIVERSITY OF HEALTH SCIENCES, İSTANBUL ZEYNEP KAMİL HEALTH RESEARCH CENTER FOR GYNAECOLOGY AND PEDIATRICS

Abstract

Introduction: There is limited and conflicting information in literature regarding use of inhaled nitric oxide (iNO) in preterm infants. In this study we examined the characteristics of preterm infants with persistent pulmonary hypertension (PHT) who responded and did not respond to iNO therapy . Material and Method: We retrospectively reviewed data of infants

Publisher

Journal of Health Sciences and Medicine

Subject

General Medicine

Reference42 articles.

1. Myers TR. Therapeutic gases for neonatal and pediatric respiratory care. Respir Care 2003; 48: 399-422.

2. Dani C, Pratesi S. Nitric oxide for the treatment of preterm infants with respiratory distress syndrome. Expert Opinion 2013; 14: 97-103.

3. Shiraishi J, Kusuda S, Cho K, et al. Standardization of nitric oxide inhalation in extremely preterm infants in Japan. Pediatr Int 2019; 61: 152-7.

4. Sasi A, Sehgal A. Use of inhaled nitric oxide in preterm infants: A regional survey of practices. Heart Lung 2014; 43: 347-50.

5. Finer N, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2017; 1: CD000399.